BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND Ki-67 AND Staging
13 results:

  • 1. Transcription factor ZNF488 accelerates cervical cancer progression through regulating the MEK/ERK signaling pathway.
    Weng K; Li L; Zhou H
    Histol Histopathol; 2023 Dec; 38(12):1381-1390. PubMed ID: 36537752
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical significance of CD34, podoplanin and ki-67 expression in patients with locally advanced squamous cell cervical carcinoma.
    Kubik S; Jesionek-Kupnicka D; Stawiski K; Fijuth J; Moszynska-Zielinska M; Kuncman L; Pajdzinski M; Gottwald L
    J Obstet Gynaecol; 2022 Aug; 42(6):2248-2254. PubMed ID: 35264072
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Value of metabolic parameters of primary lesions examined by 18F-FDG PET/CT for endometrial cancer in preoperative evaluation.
    Gai QZ; Lv YB; Li GY; Zhang DQ; Gao Z; Fang XH
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2493-2502. PubMed ID: 33829435
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. PIpelle Prospective ENDOmetrial carcinoma (PIPENDO) study, pre-operative recognition of high risk endometrial carcinoma: a multicentre prospective cohort study.
    Visser NC; Bulten J; van der Wurff AA; Boss EA; Bronkhorst CM; Feijen HW; Haartsen JE; van Herk HA; de Kievit IM; Klinkhamer PJ; Pijlman BM; Snijders MP; Vandenput I; Vos MC; de Wit PE; van de Poll-Franse LV; Massuger LF; Pijnenborg JM
    BMC Cancer; 2015 Jun; 15():487. PubMed ID: 26123742
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Expression of Vimentin and ki-67 Proteins in cervical Squamous Cell Carcinoma and their Relationships with Clinicopathological Features.
    Yu JQ; Zhou Q; Zheng YF; Bao Y
    Asian Pac J Cancer Prev; 2015; 16(10):4271-5. PubMed ID: 26028085
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinicopathology significance of p53 and p63 expression in Indonesian cervical squamous cell carcinomas.
    Romus I; Triningsih FE; Mangunsudirdjo S; Harijadi A
    Asian Pac J Cancer Prev; 2013; 14(12):7737-41. PubMed ID: 24460361
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Frequent loss of tumor suppressor ARID1A protein expression in adenocarcinomas/adenosquamous carcinomas of the uterine cervix.
    Katagiri A; Nakayama K; Rahman MT; Rahman M; Katagiri H; Ishikawa M; Ishibashi T; Iida K; Otsuki Y; Nakayama S; Miyazaki K
    Int J Gynecol Cancer; 2012 Feb; 22(2):208-12. PubMed ID: 22274316
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Expression of p53, bcl-2 and ki-67 in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
    Looi ML; Dali AZ; Ali SA; Ngah WZ; Yusof YA
    Anal Quant Cytol Histol; 2008 Apr; 30(2):63-70. PubMed ID: 18561741
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Association of p16, p53, ki-67 expressions with high-risk human papilloma virus infection in cervical intraepithelial neoplasia].
    Shi J; Zheng JS; Yin F; Hu WW; Huang XJ; Zhou XL
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):515-7. PubMed ID: 17545048
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer.
    van Westreenen HL; Cobben DC; Jager PL; van Dullemen HM; Wesseling J; Elsinga PH; Plukker JT
    J Nucl Med; 2005 Mar; 46(3):400-4. PubMed ID: 15750150
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Changes of ki-67 index in squamous cell carcinoma of the cervix during the early course of radiotherapy and prediction of prognosis.
    Kamer SA; Yalman D; Ozer E; Sayhan S; Hanhan M; Ozsaran A; Haydaroğlu A
    Eur J Gynaecol Oncol; 2003; 24(3-4):287-92. PubMed ID: 12807242
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Relationship between expression of matrix metalloproteinase (MMP-9) and tumor angiogenesis, cancer cell proliferation, invasion, and metastasis in invasive carcinoma of cervix].
    Jiang ZQ; Zhu FC; Qu JY; Zheng X; You CL
    Ai Zheng; 2003 Feb; 22(2):178-84. PubMed ID: 12600296
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Immunohistochemical evaluation is not prognostic for recurrence in fully staged high-risk endometrial cancer.
    Fanning J; Brown S; Phibbs G; Kramer T; Zaher A
    Int J Gynecol Cancer; 2002; 12(3):286-9. PubMed ID: 12060450
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.